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In Vivo Multimodal Imaging of 
Drusenoid Lesions in Rhesus 
Macaques
Glenn Yiu  1, Eric Tieu1, Christian Munevar2, Brittany Wong3, David Cunefare3, Sina Farsiu3, 
Laura Garzel4, Jeffrey Roberts2,4 & Sara M. Thomasy2
Nonhuman primates are the only mammals to possess a true macula similar to humans, and 
spontaneously develop drusenoid lesions which are hallmarks of age-related macular degeneration 
(AMD). Prior studies demonstrated similarities between human and nonhuman primate drusen based 
on clinical appearance and histopathology. Here, we employed fundus photography, spectral domain 
optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), and infrared reflectance (IR) 
to characterize drusenoid lesions in aged rhesus macaques. Of 65 animals evaluated, we identified 
lesions in 20 animals (30.7%). Using the Age-Related Eye Disease Study 2 (AREDS2) grading system 
and multimodal imaging, we identified two distinct drusen phenotypes – 1) soft drusen that are larger 
and appear as hyperreflective deposits between the retinal pigment epithelium (RPE) and Bruch’s 
membrane on SD-OCT, and 2) hard, punctate lesions that are smaller and undetectable on SD-OCT. 
Both exhibit variable FAF intensities and are poorly visualized on IR. Eyes with drusen exhibited 
a slightly thicker RPE compared with control eyes (+3.4 μm, P=0.012). Genetic polymorphisms 
associated with drusenoid lesions in rhesus monkeys in ARMS2 and HTRA1 were similar in frequency 
between the two phenotypes. These results refine our understanding of drusen development, and 
provide insight into the absence of advanced AMD in nonhuman primates.
In humans, drusen are focal deposits of extracellular debris located between the retinal pigment epithelium 
(RPE) and Bruch’s membrane, and may occur with normal aging or as a sign of age-related macular degener-
ation (AMD) - the leading cause of vision loss in the elderly. Drusen are primarily composed of lipids such as 
phosphatidylcholine, esterified cholesterol, and unesterified cholesterols1–3, as well as various proteins including 
vitronectin, crystallins, amyloid proteins, apolipoproteins, immunoglobulins, and complement components4–6. 
The advent of ocular imaging technologies has led to more refined classification of different drusen phenotypes, 
including soft drusen, cuticular drusen, and reticular pseudodrusen. Soft drusen are larger, yellow-white mounds 
that are histologically external to the RPE basement membrane. Cuticular drusen are smaller, densely-packed, 
and more uniform in size. They were previously thought to be nodular thickenings of the RPE basement mem-
brane7, but were subsequently found to be external to the basal lamina of the RPE with a similar composition 
as soft drusen8. Reticular pseudodrusen are located in the subretinal space above the RPE9,10, and may be dis-
tinguished by their location on histology and optical coherence tomography (OCT)11. These different drusen 
phenotypes are associated with certain genotypic variants such as those in the complement factor H (CFH) and 
age-related maculopathy susceptibility (ARMS2) loci, and may have differential propensity for progression to 
RPE atrophy and late-stage AMD12,13.
Most laboratory animals such as rodents are poor models of AMD and drusen due to their relative short 
lifespan and lack of a macula. In contrast, nonhuman primates are the only mammals that possess a true macula 
comparable to humans, and spontaneously develop drusenoid lesions similar to those seen in AMD. Early studies 
reported a high prevalence of drusenoid deposits in free-ranging colonies of rhesus macaques (Macaca mulatta) 
from Cayo Santiago in Puerto Rico, where drusenoid pathology was noted in 30–74% of animals14–17. Subsequent 
studies of other colonies within the continental U.S. demonstrated a lower prevalence of 5–47%18–20, likely due 
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to factors such as reduced sunlight exposure from indoor housing, more regular diet, age and genetic differences 
between colonies, as well as different methods of detecting and classifying the lesions.
Prior studies of drusenoid deposits in nonhuman primates were mostly qualitative, relying on clinical exam-
ination, fundus photography, and histological analysis to characterize the lesions. The deposits were classified as 
“hard” or “soft” based on funduscopic appearance, followed by post-mortem assessment of their histopathology. 
These studies revealed increasing frequency of drusenoid deposits with age14,21, and similar molecular composi-
tion as human drusen22. Rhesus monkeys and humans were also found to share genetic polymorphisms in genes 
such as ARMS2 and HTRA1 (high temperature-requirement factor A1) that are associated with drusen forma-
tion23–25. These studies suggest that the drusenoid deposits in nonhuman primates may offer significant insight 
into drusen formation in humans, but more refined, quantitative methods are necessary to characterize these 
lesions in monkeys for translational research.
In this study, we surveyed aged rhesus macaques (age >19 years) at the California National Primate Research 
Center (CNPRC) to identify animals with drusenoid lesions. We used the validated age-related eye disease study 
2 (AREDS2) system and digital image segmentation for grading drusen from fundus photographs in human stud-
ies26,27, then employed in vivo ocular imaging modalities, including blue-peak fundus autofluorescence (FAF), 
infrared reflectance (IR), and spectral domain-OCT (SD-OCT), to characterize the drusenoid lesions in rhe-
sus macaques in vivo. We identified two morphologic phenotypes of drusenoid deposits, which can be distin-
guished by different imaging features, and investigated potential associations between drusen phenotype with 
single-nucleotide polymorphisms in ARMS2 and HTRA1 which are known to be associated with macular drusen 
in rhesus monkeys. Comparing our results with prior studies of drusen prevalence in other primate colonies, we 
speculate on the pathogenesis of drusen formation in rhesus macaques, and the absence of advanced AMD in 
nonhuman primates.
Methods
Subjects. The CNPRC is accredited by the Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC) International. All studies using rhesus macaques (Macaca mulatta) followed the 
guidelines of the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in 
Ophthalmic and Vision Research, complied with the National Institutes of Health (NIH) Guide for the Care and 
Use of Laboratory Animals, and were approved by the University of California, Davis Institutional Animal Care 
and Use Committee. Complete ophthalmic examinations were performed in aged rhesus macaques (≥ 19 years) 
undergoing routine semi-annual physical examinations. The animals were sedated with intramuscular injection 
of ketamine hydrochloride, midazolam, and dexmedetomidine, followed by pupillary dilation with tropicamide 
(Bausch & Lomb, Tampa, FL) and cycloplegia with cyclopentolate (Akorn, Lake Forest, IL). All subjects under-
went slit lamp biomicroscopy, dilated fundus biomicroscopy, streak retinoscopy, A-scan biometry, and rebound 
tonometry. After the initial survey, multimodal imaging of the macula was performed on all animals with druse-
noid lesions identified on fundus examination, as well as a selection of age-matched control animals, including 
fundus photography, blue-peak FAF, IR imaging, and SD-OCT. Animal eyes that showed any other retinal or 
choroidal lesions on exam were excluded from this study. For all animals, age, sex, cycloplegic refraction (diop-
ters), intraocular pressure (mmHg) measured by rebound tonometry, and axial length (mm) on A-scan biometry 
were recorded.
Multimodal Ocular Imaging. Fundus photography was performed using the CF-1 Retinal Camera (Canon, 
Tokyo, Japan) with a 50-degree wide-angle lens. Blue-peak FAF and IR imaging were obtained simultaneously 
with SD-OCT using the Spectralis HRA+OCT platform (Heidelberg Engineering, Heidelberg, Germany). 
Confocal scanning laser ophthalmoscopy was used to capture 30º × 30º autofluorescence images using an excita-
tion light of 488 nm and a long-pass barrier filter starting at 500 nm, along with a 20 º × 20º SD-OCT volume scan 
with 1024 A-scans per B-scan and raster line spacing of 51 μm, centered on the fovea, in high-resolution mode. 
Infrared reflectance images were captured using an 820 nm diode laser, along with a 30 º × 5º SD-OCT raster scan 
with 1536 A-scans per B-scan and 234 μm spacing between B-scans, in high-resolution enhanced-depth imaging 
(EDI) mode. 25 scans were averaged for each B-scan, using the Heidelberg eye tracking Automatic Real-Time 
(ART) software. All imaging was performed by the first author (GY) at CNPRC. Animals were monitored by a 
trained technician and a CNPRC veterinarian (LG) at all times.
Image Analysis. Digital color fundus photographs were evaluated by two experienced image graders (GY, 
ET) using ImageJ (version 1.49v; National Institutes of Health, Bethesda, MD). Drusenoid lesions were catego-
rized using the Age-Related Eye Disease Study 2 (AREDS2) system for classification of AMD, which has been 
previously validated for grading of digital fundus photographs in human clinical trials with high reproducibil-
ity26. Grading involves a modified grid template adapted from the Early Treatment Diabetic Retinopathy Study 
(ETDRS)28, with a set of graduated circles used to estimate maximum drusen size and total area involved by pig-
ment abnormalities and drusen (Fig. 1A). The grid template was calibrated in these animals based on the ocular 
dimensions of the optic disc in rhesus macaques, which measures 1400 μm vertically and 1000 μm horizontally29, 
compared to 1800 μm in both dimensions in humans26. The radii of the modified grid template circles remain as 
1/3 DD, 1 DD, and 2 DD based on the vertical disc diameter, but are equivalent to 467 μm, 1400 μm, and 2800 μm 
respectively (Fig. 1B). Rhesus and human studies can be compared by applying a scaling constant of 0.778 for 
linear measurements, and 0.605 for area measurements. Lesions graded include area of hyperpigmentation or 
hypopigmentation; maximum size and area of drusen within the grid; presence of calcified drusen, drusenoid 
pigment epithelial detachment, or reticular drusen; presence, area, configuration, and center-involvement of 
geographic RPE atrophy; and presence of neovascular AMD (Supplemental Table 1). The details of the grading 
criteria have been extensively described26,30. Any discrepancies in grading were resolved by open adjudication 
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Figure 1. Grading and quantification of drusenoid lesions in rhesus macaques from fundus photographs. A 
representative fundus photograph of a left rhesus macaque eye with large soft drusen is shown overlaid with 
the modified Early Treatment Diabetic Retinopathy Study (ETDRS) grid template (A), along with a diagram 
of the graduated measurement circles used for estimating the drusen size and area based on a modified Age-
Related Eye Disease Study 2 (AREDS2) grading system (B). Both the grid template and measurement circles 
are calibrated to the vertical dimension of the rhesus optic nerve, which is 1400 μm in adult animals (compared 
to 1800 μm in human adults). The same representative fundus photograph is shown with manual segmentation 
of drusenoid lesions (yellow outlines), as well as the inner and outer rings (yellow circles) (C). Scatterplots 
show the inverse relationship between number of drusenoid lesions and average lesion size (D), as well as the 
association between AREDS2 drusen area grade with total segmented lesion area (E) and between AREDS2 
drusen size grade with largest segmented lesion size (F).
www.nature.com/scientificreports/
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between the graders. Manual drusen segmentation of the fundus photographs was then performed by the two 
graders by outlining individual lesions within the inner and outer ETDRS circle using the freehand selection tool 
in ImageJ as previously described27 and calibrated to the vertical diameter of the optic disc. All measurements 
were determined from the mean of the two graders’ measurements, and include the number of drusenoid lesions, 
total area of lesions, average lesion size, and size of largest lesion (Fig. 1C).
The SD-OCT images were exported from Heidelberg Explorer software (version 1.8.6.0, Heidelberg 
Engineering, Heidelberg, Germany) to Duke Optical Coherence Tomography Retinal Analysis Program 
(DOCTRAP, version 62.0)31,32, a custom image segmentation software designed using MATLAB (Mathworks, 
Natick, MA). For thickness measurements of retinal and choroidal layers, segmentation boundaries were auto-
matically determined by DOCTRAP, followed by manual refinement by two experienced graders (CM, BW) 
along a 3 mm horizontal segment centered on the fovea. Measured layers include nerve fiber layer (NFL), gan-
glion cell/inner plexiform layers (GCL/IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear 
layer (ONL), photoreceptor inner and outer segments (IS/OS), retinal pigment epithelium (RPE) which includes 
any drusenoid complex between the RPE and Bruch’s membrane, as well as the choriocapillaris (CC), and outer 
choroid (OC). The GCL/IPL were measured as a single complex due to difficulty in distinguishing between 
these layers even in normal retinal scans. The total retinal thickness was measured from the internal limiting 
membrane to Bruch’s membrane, and total choroidal thickness was measured from Bruch’s membrane to the 
choroidal-scleral junction as previously described33,34. Measurements were determined from the mean of the two 
graders’ measurements, and then averaged across the central 3mm for thickness comparisons.
Correlation in drusen size and area between left and right eyes was determined using two-tailed Pearson 
correlation. Differences in chorioretinal layer thickness measurements and differences in lesion number, size, 
and area were compared using linear regression analysis with generalized estimating equations to account for two 
eyes evaluated from each animal. The association of AREDS2 grading with segmented measurements was also 
determined using linear regression with generalized estimating equations.
Genotype Analysis. Genomic DNA from blood or buffy coat was extracted with a commercial kit (DNeasy 
Blood and Tissue Kit; Qiagen, Hilden, Germany) following the manufacturer’s protocol, and quantified using a 
spectrophotometer (NanoDrop 2000c; Thermo Fisher Scientific, Waltham, MA, USA). The region of interest was 
amplified using the following primers HTRA1-Forward 5′-TATCACTTCACTGTGGGTCCGG-3′, HTRA1-Reverse 
5′-GCGATTCGCGTCCTTCAAACTA-3′, ARMS2-Exon1-Forward 5′-GATGGCAGCTGGCTTGGCAAGG, 
ARMS2-Exon1-Reverse 5′-GGGGTAAGGCCTGATCATCTGCA-3′ with a high-fidelity DNA polymerase (Phusion 
or Q5; New England Biolabs, Ipswich, MA, USA) and purified using a PCR purification kit (QIAquick; Qiagen). 
Sanger sequencing of PCR products was performed by the University of California, Davis DNA Sequencing facility 
(Davis, CA, USA). Association of single nucleotide polymorphisms with drusen phenotype was determined using a 
Fisher’s Exact test. All statistical analyses were performed using SPSS Statistics (version 22, IBM).
Results
Demographics and Ocular Characteristics. Of 65 aged macaques (>19 years) evaluated at CNPRC, we 
identified drusenoid lesions by dilated fundus biomicroscopy in both eyes of 20 animals (30.7%). Of these ani-
mals, 10 were male, and mean age was 23.3 ± 2.7 years (range 19.3 to 29.4 years). Among the 40 eyes with druse-
noid lesions, mean intraocular pressure (IOP) was 19.1 ± 4.4 mmHg, and mean axial length was 19.8 ± 0.7 mm. 
We also selected 8 age-matched animals with no ocular findings as normal controls for ocular imaging, with a 
mean age of 23.9 ± 2.9 years (range 21.3 to 28.2 years), of which 3 were male. Among the 16 control eyes, mean 
IOP and axial length were 17.1 ± 4.5 mmHg and 19.7 ± 1.0 mm, respectively. No statistical differences in age 
(P = 0.609), sex (P = 0.401), IOP (P = 0.298), and axial length (P = 0.945) were observed between the two groups 
of animals.
AREDS2 Classification of Drusenoid Lesions on Fundus Photography. Among the 40 eyes noted to 
have drusenoid lesions on fundus examination, 34 eyes had fundus photographs with adequate quality for grad-
ing of drusenoid lesions (Table 1). Using the AREDS2 classification for drusen size, the majority of lesions were 
classified as “small” (grade 2, ≤59 μm diameter) or “large” (grade 4, >116 μm diameter), with similar proportions 
of each. A majority of eyes with drusenoid lesions had a total lesion area between grading circles I-2 (0.089 
mm2) and O-2 (0.297 mm2). Left and right eyes of individual animals showed a strong correlation in drusen size 
(r = 0.989; P < 0.001) and area (r = 0.970; P < 0.001). No cases of calcified drusen, drusenoid pigment epithelial 
detachment, or reticular drusen were identified in any of the fundus photographs. There was also no evidence of 
hyperpigmentation, hypopigmentation, geographic atrophy, or neovascular AMD noted in any eye in this cohort 
of macaques.
We noted that drusenoid lesions in rhesus macaques adapted either a “soft” drusen or “hard” punctate appear-
ance, based on the original AREDS terminology for drusen type. When classified in this manner, eyes with pre-
dominantly soft drusen showed significantly larger drusen size (P < 0.001) and a trend toward greater total lesion 
area (P = 0.102; Table 1). Some eyes with soft drusen also showed hard punctate lesions, while eyes with predom-
inantly hard lesions rarely showed any soft drusen. Fellow eyes showed perfect correlation (r = 1.000; P < 0.001) 
in predominant lesion phenotype classified in this manner. Lesions were occasionally noted outside of the central 
macula, although only one animal exhibited any significant drusen (area ≥ 0.297 mm2) beyond the 5.6mm outer 
circle of the ETDRS grid (Table 1).
Quantification of Drusenoid Lesions on Fundus Photography. Of eyes with digital fundus pho-
tographs, 21 were found to be adequate for image segmentation of individual drusenoid lesions. Quantitative 
drusen segmentation showed an inverse association between lesion size and number of lesions (Fig. 1D). Eyes 
www.nature.com/scientificreports/
5Scientific RepoRts | 7: 15013  | DOI:10.1038/s41598-017-14715-z
with primarily soft drusen showed fewer number of lesions (P = 0.006) and larger average lesion size (P < 0.001), 
with a trend toward greater total lesion area (P = 0.297; Table 2). AREDS2 drusen area and size grading correlated 
well with the total lesion area and size of largest lesion as measured from image segmentation (P < 0.001 for both) 
(Fig. 1E,F). Hence, both AREDS2 grading and quantitative measurements from drusen segmentation demon-
strate the distinct size and distribution of these two lesion phenotypes.
Comparison of Drusenoid Lesions on OCT and FAF. Image analysis of soft and hard lesions showed 
distinct characteristics on multimodal ocular imaging. Soft drusen (Fig. 2A) have a variable appearance on FAF 
imaging, with some lesions appearing more hyper-autofluorescent, and others having a more iso-autofluorescent 
appearance (Fig. 2B). Near IR imaging of the ocular fundus in rhesus macaques showed a mottled appearance 
corresponding to the underlying choroidal vascular architecture, and the drusenoid deposits are difficult to 
distinguish (Fig. 2C). On SD-OCT, the soft deposits appear as dome-shaped hyperreflective deposits located 
between the RPE and Bruch’s membrane (Fig. 2D–G). Deposits show variable autofluorescence intensities, with 
some larger lesions appearing more hyper-autofluorescent (Fig. 2D), while some less elevated ones show a less 
intense autofluorescence signature and may appear as focal thickening of the RPE itself (Fig. 2E–G). There was no 
clear disruption of the outer retinal layers, such as the external limiting membrane (ELM) or inner segment-outer 
segment (IS-OS) junction; or changes to the underlying choriocapillaris, which appear in rhesus macaques as a 
distinct hyporeflective band as our group has described recently35. The cone outer-segment tip (COST) lines, also 
known as the interdigitation zone, were variably visible in different animals, and showed no consistent difference 
between normal subjects and those with either drusen phenotype.
Hard punctate lesions (Fig. 3A) also have a variable appearance on FAF imaging, with some lesions appearing 
more hyper-autofluorescent while others are not as readily discernable (Fig. 3B). Rarely, these lesions may appear 
on near IR imaging (Fig. 3C), but most of the lesions could not be distinguished by this modality. Interestingly, 
the small punctate lesions were uniformly undetectable on even high density SD-OCT scans, with no visible dis-
ruptions of the RPE, outer retinal layers, or choroidal vasculature (Fig. 3D–G). Hence, these hard lesions do not 
appear to represent true sub-RPE deposits as in AMD drusen.
Retinal and Choroidal Layer Thicknesses. To compare retinal and choroidal thicknesses, we employed 
a custom, semi-automated segmentation software to measure the average thicknesses of individual layers across 
the central 3mm along a horizontal SD-OCT line scan through the fovea (Fig. 4A–B). Among the animals, 23 
eyes with drusen and 14 eyes from age-matched controls had SD-OCT images of adequate quality for thickness 
measurements. Among these eyes, total retinal and choroidal thickness, as well as the thicknesses of individual 
layers, were similar between the two groups (Fig. 4C–D), with the exception of the RPE which was statistically 
Any Drusen (n = 40) Soft Drusen (n = 16)
Hard Lesions 
(n = 18) P-value
Drusen size (largest) <0.001*
0: None 0 0 0
1: Questionable 0 0 0
2: Definite, diameter < C-0& 17 0 17
3: Diameter > C-0, but < C-1 1 0 1
4: Diameter > C-1, but < C-2 15 15 0
5: Diameter > C-2 1 1 0
8: Cannot grade 6 0 0
Drusen area# 0.102
0: Questionable, or total area < C-0 0 0 0
1: Area ≥ C-0, but < C-1 0 0 0
2: Area ≥ C-1, but < C-2 2 0 2
3: Area ≥ C-2, but < I-2 4 1 3
4: Area ≥ I-2, but < O-2 16 7 9
5: Area ≥ O-2, but < ½ DA 7 3 4
6: Area ≥ ½ DA, but < 1DA 2 1 1
7: Area ≥ 1DA 3 3 0
8: Cannot grade 6 0 0
Drusen outside grid cannot compute
0: None, questionable, or area < O-2 33 15 18
5: Area ≥ O-2 1 1 0
8: Cannot grade 6 0 0
Table 1. Fundus photograph grading of drusenoid lesions in Rhesus macaques using the AREDS2 classification 
system. *Statistically significant. #Area within modified Early Treatment of Diabetic Retinopathy Study (ETDRS) 
grid. &The circular areas for grading measured in square millimeters are: C-0 = 0.003 mm2, C-1 = 0.011 mm2, 
C-2 = 0.043 mm2, I-2 = 0.089 mm2, O-2 = 0.297 mm2, 1/2 disc area (DA) = 0.77 mm2, 1 DA = 1.54 mm2.
www.nature.com/scientificreports/
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thicker in eyes with drusenoid lesions by approximately 3.4 μm (P = 0.012; Table 3). When comparing eyes with 
predominantly soft drusen versus hard punctate lesions (Fig. 4E,F), there were no significant differences in any of 
the retinal or choroidal layers (Table 3).
Genotype of Animals with Drusenoid Lesions. Genetic polymorphisms in the ARMS2 and HTRA1 
loci associated with drusenoid lesions in rhesus macaques have been independently confirmed in colony animals 
from the Oregon National Primate Research Center, the Caribbean Primate Research Center (CPRC), and the 
German Primate Center (Deutsche Primatenzentrum or DPZ) in Gottingen, the majority of which originated 
from the CPRC colony from Cayo Santiago23–25. In our cohort of animals, the high-risk allele in the ARMS2 locus 
(SNP position 10682 T > C) occurred at a higher frequency (70.7%) than previously reported at CPRC (20.3%) or 
DPZ (49.2%), with no significant difference between eyes with and without drusenoid lesions (P = 1.000; Table 4). 
The risk allele in HTRA1 (SNP position 17076 C > A) occurred at much lower frequency (4.6%) than the other 
colonies (21.0% to 60.0%), and also showed no association with presence of drusenoid lesions (P = 0.176). When 
comparing animals with the soft drusen and hard lesions, we found no difference in risk allele distribution in 
either the ARMS2 (P = 0.793) or HTRA1 (P = 0.471) loci. Our results suggest that the genetic factors previously 
Any Drusen (n = 21) Soft Drusen (n = 9) Hard Lesions (n = 12) P-value
Number of Lesions 181.5 ± 174.7# 67.7 ± 44.9 266.9 ± 188.4 0.006*
Total Area of Lesions (mm2) 0.418 ± 0.414 0.568 ± 0.558 0.305 ± 0.233 0.297
Average Lesion Size (mm2) 0.004 ± 0.004 0.007 ± 0.004 0.001 ± 0.001 <0.001*
Size of Largest Lesion (mm2) 0.015 ± 0.015 0.027 ± 0.016 0.006 ± 0.005 0.001*
Table 2. Fundus photograph quantification of drusenoid lesions in Rhesus macaques using digital image 
segmentation. *Statistically significant. #All values expressed as mean ± standard deviation.
Figure 2. Multimodal imaging of soft drusen in rhesus macaques. Fundus photographs (A), as well as fundus 
autofluorescence (B), infrared reflectance (C), and spectral-domain optical coherence tomography (D–G) 
images of a right eye of a rhesus macaque with large soft drusen are shown, with corresponding drusen labeled 
with yellow, red, green, and blue circles (A–C) and lines (D–G). The colored dashed lines in (B) correspond to 
the line-scan segment shown in (D–G). Scale bars: 500 μm.
www.nature.com/scientificreports/
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found to confer increased risk of developing drusen in other rhesus colonies, may not contribute as strongly in 
our cohort of animals at CNPRC.
Discussion
Nonhuman primates are the only mammals that spontaneously develop drusenoid lesions similar to those in 
humans, and thus have significant translational potential as an animal model for developing therapies for AMD. 
Ocular imaging technologies are often employed in macaques for preclinical testing of novel treatments or drugs, 
but rarely for understanding the pathophysiology of age-related retinal changes that mimic human disease. In 
this study, we employed validated measures of drusenoid lesions from fundus photographs, as well as a bat-
tery of ocular imaging modalities employed in human clinical studies, to provide the first robust, quantitative 
characterization of drusenoid lesions in rhesus macaques. We describe two distinct clinical phenotypes of “soft” 
drusen and “hard” punctate lesions that can be distinguished by their size on fundus photographs and appearance 
on SD-OCT. We also provide important normative macular thickness values of retinal and choroidal layers on 
SD-OCT, and found a slightly thicker RPE in macaque eyes with drusenoid lesions. Taken together, these data 
provide an important framework for research in drusen formation and AMD using rhesus macaques.
The AREDS2 system for grading AMD lesions is derived from major clinical trials sponsored by the National 
Eye Institute to study the effects of nutritional antioxidant supplements including lutein and zeaxanthin in 
humans with AMD. This validated system is highly reproducible and predictive of 5-year risk for progression 
to advanced AMD in humans, which is defined by the presence of center-involving RPE atrophy or neovascular 
AMD36. Interestingly, neither form of advanced AMD has ever been clearly documented in nonhuman primates, 
and we did not identify any cases in our survey of the rhesus colony at CNPRC. One explanation is that the 
occurrence is so rare that it has not yet been observed in animals under study. The drusen grading in most of our 
cohort was equivalent to an AREDS severity scale of 4, which in humans correspond to a rate of only 4.8% for 
progression to advanced AMD over 5 years30. Many of the animals in the study are near the end of their lifespan, 
and thus may not survive long enough for this progression to occur. Rhesus macaques also do not have the same 
genetic risk factors for AMD as humans. Among a selection of 42 human DNA markers associated with drusen, 
24 have been identified in rhesus monkeys, of which only 7 were polymorphic37, and only the ARMS2/HTRA1 
Figure 3. Multimodal imaging of hard punctate lesions in rhesus macaques. Fundus photographs (A), as well 
as fundus autofluorescence (B), infrared reflectance (C), and spectral-domain optical coherence tomography 
(D–G) images of a right eye of a rhesus macaque with hard, punctate lesions are shown, with corresponding 
lesions labeled with yellow, red, green, and blue circles (A–C) and lines (D–G). The colored dashed lines in (B) 
correspond to the line-scan segment shown in (D–G). Scale bars: 500 μm.
www.nature.com/scientificreports/
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loci have been found to be associated with drusen in these animals23–25. In addition, our study animals are par-
tially housed indoors (mean outdoor time 53.6 ± 34.0%), and may have a healthier diet and lower sun exposure 
compared to their free-ranging counterparts. Studies have shown that rhesus monkeys fed a diet lacking macular 
pigment carotenoids lutein and zeaxanthin are more susceptible to blue-light damage and may develop drusen at 
an earlier age38,39, suggesting that standard laboratory diets low in fat and rich in xanthophylls may limit drusen 
progression also. In fact, we found only a 30.7% prevalence of drusenoid lesions in our rhesus colony at CNPRC 
compared to the 47% noted from the same colony surveyed 22 years ago20, and up to rates as high as 74% at other 
sites17, despite surveying an older cohort of animals (Table 5). From an anatomic standpoint, macaques have very 
dark uveal pigmentation40, which in humans is protective against AMD41. None of the animals we examined 
demonstrated pigmentary changes in the macula, which are also strongly-associated with AMD progression in 
humans30. In contrast, macular pigmentary changes have been more frequently reported in free-ranging animal 
colonies with incidences of up to 32%15,18. Thus, developing nonhuman primate models with more advanced 
Figure 4. Image segmentation and thickness measurement of retinal and choroidal layers in rhesus macaques. 
Spectral-domain optical coherence tomography images from a normal age-matched eye (A) and an eye with soft 
drusen (B), with and without segmentation lines, are shown. Thickness of individual retinal and choroidal layers 
are shown for age-matched normal eyes (C), eyes with any drusenoid lesions (D), eyes with predominantly soft 
drusen (E), and eyes with hard, punctate lesions (F). Abbreviations: NFL, nerve fiber layer; GCL/IPL, ganglion 
cell/inner plexiform layers; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; IS, 
inner segments of photoreceptors; OS, outer segments of photoreceptors; RPE, retinal pigment epithelium; CC, 
choriocapillaris; C, outer choroid. Scale bar: 500 μm.
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stages of AMD may require long-term dietary and environmental modifications that better represent human 
behavior. Interestingly, Japanese macaques (Macaca fuscata) have an early-onset form of drusen with a dominant 
mode of inheritance42. Cynomologus macaques (Macaca fascicularis) also develop drusen in an age-dependent 
manner with a potential link to hematologic markers43. Thus, the quantitative and imaging techniques used in our 
study may provide the necessary platform to study other nonhuman primate models of AMD in a more rigorous 
manner.
Modern ocular imaging technologies such as SD-OCT and FAF provide new ways to characterize drusen 
phenotypes in humans and macaques. SD-OCT of soft drusen in rhesus monkeys appear as dome-shaped hyper-
reflective deposits under the RPE, which is very similar to those seen in AMD44–47. However, the soft drusen in 
macaques appear more uniform in morphology, and lack any reflective drusen substructures or hyperreflective 
foci in the overlying outer retina which are predictive of progression to geographic atrophy in humans47,48. We 
also did not find any reticular pseudodrusen, which are more strongly associated with geographic atrophy49, in 
any of the aged animals in our colony. The absence of these drusen abnormalities may further explain the absence 
Normal Eyes (n = 14) Any Drusen (n = 23) P-value
Total retinal thickness 292.6 ± 21.4 314.0 ± 69.7 0.198
Nerve fiber layer (NFL) 15.7 ± 1.6 17.8 ± 4.6 0.051
Ganglion cell/inner plexiform layer (GCL/IPL) 51.5 ± 10.2 57.5 ± 15.7 0.244
Inner nuclear layer (INL) 29.8 ± 7.9 31.8 ± 7.7 0.515
Outer plexiform layer (OPL) 21.0 ± 3.0 23.1 ± 6.0 0.182
Outer nuclear layer (ONL) 83.3 ± 6.7 88.5 ± 17.4 0.253
Photoreceptor inner segments (IS) 33.0 ± 1.9 35.1 ± 7.6 0.208
Photoreceptor outer segments (OS) 41.7 ± 4.5 40.3 ± 10.4 0.599
Retinal pigment epithelium (RPE) 16.5 ± 2.7 19.9 ± 4.6 0.012*
Choriocapillaris (CC) 20.2 ± 4.9 19.6 ± 3.3 0.728
Outer choroid (C) 158.8 ± 23.2 173.2 ± 40.5 0.202
Total choroidal thickness 179.1 ± 25.0 192.8 ± 41.7 0.246
Soft Drusen (n = 12) Hard Lesions (n = 11) P-value
Total retinal thickness 306.8 ± 15.4 321.8 ± 101.4 0.630
Nerve fiber layer (NFL) 16.7 ± 1.5 19.2 ± 6.3 0.202
Ganglion cell/inner plexiform layer (GCL/IPL) 55.1 ± 6.8 60.0 ± 21.9 0.487
Inner nuclear layer (INL) 31.1 ± 3.9 32.6 ± 10.6 0.667
Outer plexiform layer (OPL) 21.3 ± 2.8 25.0 ± 8.0 0.143
Outer nuclear layer (ONL) 90.8 ± 5.1 85.9 ± 24.9 0.528
Photoreceptor inner segments (IS) 33.6 ± 0.8 36.7 ± 11.0 0.354
Photoreceptor outer segments (OS) 38.5 ± 4.4 42.2 ± 14.4 0.415
Retinal pigment epithelium (RPE) 19.7 ± 2.9 20.1 ± 6.1 0.844
Choriocapillaris (CC) 19.9 ± 3.3 19.3 ± 3.5 0.663
Outer choroid (C) 167.2 ± 38.0 179.7 ± 44.0 0.503
Total choroidal thickness 187.2 ± 37.7 199.0 ± 46.7 0.537
Table 3. Retinal and choroidal layer thicknesses of age-matched normal eyes and eyes with drusenoid lesions in 
rhesus macaques. *Statistically significant.
Genotype
Frequency
P-valueNormal Eyes Any Drusen
ARMS2 
SNP 10682
TT  
CT  
CC
4  
19  
22
1  
9  
10
1.000
HTRA1 
SNP 17076
CC  
AC  
AA
43  
0  
2
18  
2  
0
0.176
Soft Drusen Hard Lesions
ARMS2 
SNP 10682
TT  
CT  
CC
1  
3  
4
0  
3  
6
0.793
HTRA1 
SNP 17076
CC  
AC  
AA
7  
1  
0
9  
0  
0
0.471
Table 4. Frequencies of risk alleles in ARMS2 and HTRA1 associated with drusen in rhesus macaques. 
Abbreviations: SNP, Single-nucleotide polymorphisms.
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of any advanced AMD phenotype in nonhuman primates. Although we noted extramacular drusen in a selec-
tion of animals, their association with AMD progression in humans remain unclear. Peripheral drusen are more 
frequently observed in AMD patients, but may not be associated with major genetic risk alleles for AMD such as 
CFH and ARMS250. Further studies using ultrawide-field imaging may better characterize the role of extramac-
ular drusen in rhesus macaques51.
In this study, we also described hard, punctate lesions in rhesus macaques that are undetectable on SD-OCT. 
We cannot exclude the possibility that the lesions are so small that they are below the detection threshold of 
SD-OCT, although this is unlikely since the imaging system has an axial resolution of 3.87 μm per pixel, a trans-
verse resolution of 4.82 μm per pixel, and a line scan density of 51 μm between B-scans, compared to the large 
number of punctate lesions sampled which on average were approximately 10 μm in diameter on fundus pho-
tographs. Interestingly, similar small hypopigmented lesions have been described on histology in macaques as 
a form of lipoidal degeneration where RPE cells become filled with vacuoles and lipid droplets, rather than true 
sub-RPE deposits as seen with AMD drusen52–54. It is unclear, however, whether these punctate lesions represent a 
separate entity or are precursors to larger soft drusen. We noted that eyes with mostly soft drusen also have punc-
tate lesions, but those with predominantly hard lesions rarely exhibit any soft drusen. Animals with soft drusen 
are also older than those with mainly hard drusen (25.2 ± 2.5 years vs. 22.3 ± 2.2 years; P = 0.024). Finally, while 
eyes with drusenoid lesions demonstrated RPE thickening, there was no significant difference in RPE thickness 
between animals with soft drusen or hard lesions. Together, these evidences suggest that the two drusen pheno-
types may be different manifestations of the same pathophysiological process, and that hard, punctate lesions may 
occur at an earlier stage. This is further supported by the similar distribution of risk alleles in ARMS2 and HTRA1 
between animals with the two drusen phenotypes. Since SD-OCT imaging affords the ability to monitor morpho-
logic changes of these lesions over time, future longitudinal studies using SD-OCT and fundus photography may 
enhance our understanding of drusen progression in nonhuman primates.
FAF imaging provides another measure of disease activity in retinal conditions, although the precise source 
of the autofluorescence remains controversial55–57. Many hypothesize that blue-peak FAF is a measure of lipofus-
cin, autofluorescent pigment granules in RPE cells that result from lysosomal digestion of photoreceptor outer 
segments58. Rhesus monkeys deficient in lutein, zeaxanthin, and omega-3 fatty acids, for example, may exhibit 
elevated FAF intensities and are also associated with higher incidences of drusen lesions59. However, the FAF 
signature of macaque drusen have never been clearly explored. In humans, drusen may exhibit variable FAF pat-
terns, likely due to differences in drusen size, composition, and effects on overlying RPE and photoreceptors60,61. 
In our study, different drusenoid lesions exhibit distinct levels of FAF, and may represent variable amounts and 
types of fluorophores within the lesions themselves or different stages of lipofuscin accumulation or RPE degen-
eration. Thus, including FAF imaging with longitudinal studies may further our insight into the pathophysiology 
of drusen development and RPE atrophy in these animals62,63.
Our study employs a systematic approach using multimodal ocular imaging to characterize and monitor 
drusenoid lesions in the aged rhesus colony at CNPRC. In contrast to prior reports from other primate centers 
where the prevalence of drusenoid lesions is higher, the current study is limited by the smaller cohort of affected 
animals at CNPRC. Compared to human subjects, ocular imaging of macaques is more challenging, with occa-
sional ocular pathologies such as corneal scars or senile cataracts limiting our ability to attain high-resolution 
images in every animal. Also, while the AREDS2 grading system has been validated in human studies, the mod-
ified form calibrated from the anatomic dimensions of the macaque fundus still require further assessment. 
Nevertheless, using the tools developed in this research, future studies to characterize the progression of druse-
noid lesions in rhesus macaques will be imperative toward establishing a powerful nonhuman primate model of 
AMD.
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